Regulation .14 Physical and Chemical Restraints.
Regulation .14 Physical and Chemical Restraints.LinkCopy Citation
A.
Physical restraints may be used only:
(1)
As an integral part of an individual medical treatment plan;
(2)
If absolutely necessary to protect the resident or others from injury;
(3)
If prescribed by a physician or administered by another health care professional practicing within the scope of their license; and
(4)
If less restrictive alternatives were considered and appropriately ruled out by the physician.
B.
Use of Physical Restraints.
(1)
When a facility uses physical restraints, personnel:
(a)
Trained in the use of restraints shall check a resident in restraint at least every 2 hours, and maintain a record of the checks and usage; and
(b)
Shall provide opportunities for motion and exercise during each 2-hour period in which physical restraint is used, and shall monitor the use of the restraint use and maintain a record of it.
(2)
The attending physician shall ensure that treatment plans include provisions for the progressive elimination of physical restraints.
C.
Use of Psychopharmacologic Drugs. When a physician prescribes psychopharmacologic drugs for a resident, the resident's clinical records shall contain all of the following documentation:
(1)
A physician's indication that the dosage, duration, indication, and monitoring are clinically appropriate and the reasons why they are clinically appropriate;
(2)
Indication that the resident is being monitored for adverse complications of the drug therapy;
(3)
Confirmation that previous attempts at dosage reduction have been unsuccessful, if applicable;
(4)
Evidence of the resident's subjective or objective improvement, or maintenance or function, while taking the medication;
(5)
Evidence that the resident's decline or deterioration, if applicable, has been evaluated by the interdisciplinary team to determine whether a particular drug, a particular dosage, or duration of therapy may be the cause;
(6)
Evidence of why the resident's age, weight, or other factors would require a unique drug dose, drug duration, indication, or monitoring; or
(7)
Other evidence that substantiates the use of the restraint.